Candel Therapeutics Inc. (NASDAQ: CADL) Stock Information | RedChip

Candel Therapeutics Inc. (NASDAQ: CADL) Listen to this Section


$5.49
+0.1100 ( +2.05% ) 43.4K

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Market Data


Open


$5.49

Previous close


$5.38

Volume


43.4K

Market cap


$175.83M

Day range


$5.35 - $5.57

52 week range


$0.66 - $14.30

Insider Ownership Transactions

Total Amount Purchased: -137,123.00 | $ -752,805.27

Date Type Amount Purchased Purchaser
2024-07-19 Sale -14851.00 Tyagarajan Seshu
2024-07-19 Sale -22528.00 Tak Paul Peter
2024-07-19 Sale -14051.00 Barone Francesca
2024-07-19 Sale -9884.00 Schoch Charles
2024-07-19 Sale -10875.00 Nichols William Garrett
2024-07-15 Sale -9769.00 Nichols William Garrett
2024-07-15 Sale -12645.00 Barone Francesca
2024-07-15 Sale -20293.00 Tak Paul Peter
2024-07-15 Sale -13330.00 Tyagarajan Seshu
2024-07-15 Sale -8897.00 Schoch Charles

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 76 Aug 13, 2024
8-k 8K-related 13 Aug 13, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 15, 2024
4 Insider transactions 1 Jul 15, 2024
4 Insider transactions 1 Jul 15, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.